A 52-week update of a multicentre real-life experience on effectiveness and safety of risankizumab in psoriasis

被引：14
|
作者：
Hansel, K. [1 ]
Zangrilli, A. [2 ]
Bianchi, L. [1 ,2 ]
Peris, K. [3 ]
Chiricozzi, A. [3 ]
Offidani, A. [4 ]
Diotallevi, F. [4 ]
Fargnoli, M. C. [5 ]
Esposito, M. [5 ]
Amerio, P. [6 ]
Gualdi, G. [6 ]
Bianchi, L. [1 ,2 ]
Stingeni, L. [1 ]
机构：
[1] Univ Perugia, Dept Med & Surg, Dermatol Sect, Perugia, Italy
[2] Univ Roma Tor Vergata, Dept Syst Med, Policlin Tor Vergata, Dermatol Unit, Rome, Italy
[3] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, Dermatol, Rome, Italy
[4] Polytech Univ Marche Reg, Dept Clin & Mol Sci, Dermatol Clin, Ancona, Italy
[5] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Dermatol, Laquila, Italy
[6] Univ G dAnnunzio, Dermatol Clin, Dept Med & Aging Sci, Chieti, Italy
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2022年 / 36卷 / 02期
关键词：
D O I：
10.1111/jdv.17656
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E111 / E113
页数：3
相关论文
共 50 条
  • [1] Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience
    Caldarola, Giacomo
    Zangrilli, Arianna
    Palmisano, Gerardo
    Bavetta, Mauro
    Moretta, Gaia
    Pagnanelli, Gianluca
    Panasiti, Vincenzo
    Bianchi, Luca
    De Simone, Clara
    Peris, Ketty
    [J]. DRUGS IN CONTEXT, 2023, 12
  • [2] Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study
    Gargiulo, Luigi
    Ibba, Luciano
    Pavia, Giulia
    Vignoli, Carlo Alberto
    Piscazzi, Francesco
    Valenti, Mario
    Sanna, Federica
    Perugini, Chiara
    Avagliano, Jessica
    Costanzo, Antonio
    Narcisi, Alessandra
    [J]. DERMATOLOGY AND THERAPY, 2022, 12 (10) : 2309 - 2324
  • [3] Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study
    Luigi Gargiulo
    Luciano Ibba
    Giulia Pavia
    Carlo Alberto Vignoli
    Francesco Piscazzi
    Mario Valenti
    Federica Sanna
    Chiara Perugini
    Jessica Avagliano
    Antonio Costanzo
    Alessandra Narcisi
    [J]. Dermatology and Therapy, 2022, 12 : 2309 - 2324
  • [4] One Dose Risankizumab Effectiveness in Psoriasis: A Real-Life Multicentre Study
    Magdaleno-Tapial, Jorge
    Ortiz-Salvador, Jose Maria
    Santos-Alarcon, Sergio
    Belinchon-Romero, Isabel
    Sahuquillo-Torralba, Antonio
    Gonzalez-Delgado, Victor
    Sabater-Abad, Javier
    Armengot-Carbo, Miquel
    Mari-Ruiz, Juan Ignacio
    Mateu-Puchades, Almudena
    Mataix-Diaz, Javier
    Schneller-Pavelescu, Luca
    Carmena-Ramon, Rafael
    Martorell, Antonio
    Sanchez-Carazo, Jose Luis
    [J]. DERMATOLOGIC THERAPY, 2024, 2024
  • [5] Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis)
    Narcisi, Alessandra
    Valenti, Mario
    Gargiulo, Luigi
    Ibba, Luciano
    Amoruso, Fabrizio
    Argenziano, Giuseppe
    Bardazzi, Federico
    Burlando, Martina
    Carrera, Carlo Giovanni
    Damiani, Giovanni
    Dapavo, Paolo
    Dini, Valentina
    Franchi, Chiara
    Girolomoni, Giampiero
    Guarneri, Claudio
    Loconsole, Francesco
    Sampogna, Francesca
    Travaglini, Massimo
    Malagoli, Piergiorgio
    Costanzo, Antonio
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (01) : 93 - 103
  • [6] Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life study
    Megna, Matteo
    Potestio, Luca
    Ruggiero, Angelo
    Camela, Elisa
    Fabbrocini, Gabriella
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (07)
  • [7] Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience
    Gargiulo, Luigi
    Piscazzi, Francesco
    Ibba, Luciano
    Valenti, Mario
    Facheris, Paola
    Perugini, Chiara
    Costanzo, Antonio
    Narcisi, Alessandra
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [8] A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis
    Stingeni, Luca
    Bianchi, Leonardo
    Antonelli, Elettra
    Caroppo, Elena Sofia
    Ferrucci, Silvia Mariel
    Gurioli, Carlotta
    Ortoncelli, Michela
    Fabbrocini, Gabriella
    Nettis, Eustachio
    Schena, Donatella
    Napolitano, Maddalena
    Gola, Massimo
    Bonzano, Laura
    Rossi, MariaTeresa
    Belloni Fortina, Anna
    Balato, Anna
    Peris, Ketty
    Foti, Caterina
    Guarneri, Fabrizio
    Romanelli, Marco
    Patruno, Cataldo
    Savoia, Paola
    Esposito, Maria
    Russo, Filomena
    Errichetti, Enzo
    Bianchelli, Tommaso
    Bianchi, Luca
    Pellacani, Giovanni
    Feliciani, Claudio
    Offidani, Annamaria
    Corazza, Monica
    Micali, Giuseppe
    Milanesi, Nicola
    Malara, Giovanna
    Chiricozzi, Andrea
    Tramontana, Marta
    Hansel, Katharina
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (03) : E384 - E388
  • [9] A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic
    Hansel, K.
    Zangrilli, A.
    Bianchi, L.
    Peris, K.
    Chiricozzi, A.
    Offidani, A.
    Diotallevi, F.
    Fargnoli, M. C.
    Esposito, M.
    Amerio, P.
    Gualdi, G.
    Bianchi, L.
    Stingeni, L.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (03) : E169 - E170
  • [10] Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort
    Colella, Francesco Molica
    Zizzo, Gaetano
    Parrino, Vincenzo
    Filosa, Maria Teresa
    Cavaliere, Riccardo
    Fazio, Francesco
    Colella, Aldo BiagioMolica
    Mazzone, Antonino
    [J]. ADVANCES IN RHEUMATOLOGY, 2023, 63 (01)
12345